Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
Total Valuation
Quest Diagnostics has a market cap or net worth of $20.27B. The enterprise value is $27.60B.
Market Cap$20.27B
Enterprise Value$27.60B
Share Statistics
Quest Diagnostics has 111,242,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding111,242,360
Owned by Insiders0.43%
Owned by Institutions0.54%
Financial Efficiency
Quest Diagnostics’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 6.96%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.96%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee179.49K
Profits Per Employee16.75K
Employee Count55,000
Asset Turnover0.61
Inventory Turnover35.26
Valuation Ratios
The current PE Ratio of Quest Diagnostics is 21.4. Quest Diagnostics’s PEG ratio is 6.95.
PE Ratio21.4
PS Ratio1.70
PB Ratio2.47
Price to Fair Value2.47
Price to FCF18.42
Price to Operating Cash Flow10.82
PEG Ratio6.95
Income Statement
In the last 12 months, Quest Diagnostics had revenue of 9.87B and earned 871.00M in profits. Earnings per share was 7.80.
Revenue9.87B
Gross Profit3.24B
Operating Income1.35B
Pretax Income1.19B
Net Income871.00M
EBITDA1.89B
Earnings Per Share (EPS)7.80
Cash Flow
In the last 12 months, operating cash flow was 1.89B and capital expenditures -492.00M, giving a free cash flow of 1.39B billion.
Operating Cash Flow1.89B
Free Cash Flow1.39B
Free Cash Flow per Share12.52
Dividends & Yields
Quest Diagnostics pays an annual dividend of $0.8, resulting in a dividend yield of 1.75%
Dividend Per Share$0.8
Dividend Yield1.75%
Payout Ratio65.22%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.21
52-Week Price Change17.76%
50-Day Moving Average182.43
200-Day Moving Average172.11
Relative Strength Index (RSI)44.22
Average Volume (3m)995.30K
Important Dates
Quest Diagnostics upcoming earnings date is Jan 29, 2026, Before Open (Confirmed).
Last Earnings DateOct 21, 2025
Next Earnings DateJan 29, 2026
Ex-Dividend DateOct 03, 2025
Financial Position
Quest Diagnostics as a current ratio of 1.10, with Debt / Equity ratio of 87.93%
Current Ratio1.10
Quick Ratio1.02
Debt to Market Cap0.39
Net Debt to EBITDA3.45
Interest Coverage Ratio5.96
Taxes
In the past 12 months, Quest Diagnostics has paid 273.00M in taxes.
Income Tax273.00M
Effective Tax Rate0.23
Enterprise Valuation
Quest Diagnostics EV to EBITDA ratio is 12.29, with an EV/FCF ratio of 25.61.
EV to Sales2.36
EV to EBITDA12.29
EV to Free Cash Flow25.61
EV to Operating Cash Flow17.45
Balance Sheet
Quest Diagnostics has $432.00M in cash and marketable securities with $6.38B in debt, giving a net cash position of -$5.95B billion.
Cash & Marketable Securities$432.00M
Total Debt$6.38B
Net Cash-$5.95B
Net Cash Per Share-$53.49
Tangible Book Value Per Share-$33.54
Margins
Gross margin is 33.30%, with operating margin of 13.63%, and net profit margin of 8.82%.
Gross Margin33.30%
Operating Margin13.63%
Pretax Margin12.09%
Net Profit Margin8.82%
EBITDA Margin19.19%
EBIT Margin14.19%
Analyst Forecast
The average price target for Quest Diagnostics is $200.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$200.20
Price Target Upside11.06% Upside
Analyst ConsensusModerate Buy
Analyst Count11
Revenue Growth Forecast13.74%
EPS Growth Forecast14.87%